XML 39 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Segment and Geographical Information (Tables)
 3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
 
March 31,

 
April 1,

(In millions)
 
2018

 
2017

 
 
 
 
 
Revenues
 
 
 
 
Life Sciences Solutions
 
$
1,499

 
$
1,363

Analytical Instruments
 
1,257

 
1,052

Specialty Diagnostics
 
947

 
866

Laboratory Products and Services
 
2,413

 
1,699

Eliminations
 
(263
)
 
(215
)
 
 
 
 
 
Consolidated revenues
 
5,853

 
4,765

 
 
 
 
 
Segment Income (a)
 
 
 
 
Life Sciences Solutions
 
517

 
433

Analytical Instruments
 
246

 
192

Specialty Diagnostics
 
243

 
233

Laboratory Products and Services
 
280

 
216

 
 
 
 
 
Subtotal reportable segments (a)
 
1,286

 
1,074

 
 
 
 
 
Cost of revenues charges
 
(3
)
 
(31
)
Selling, general and administrative charges, net
 
(8
)
 
(31
)
Restructuring and other costs, net
 
(45
)
 
(24
)
Amortization of acquisition-related intangible assets
 
(444
)
 
(368
)
 
 
 
 
 
Consolidated operating income
 
786

 
620

Other expense, net (b)
 
(152
)
 
(117
)
 
 
 
 
 
Income from continuing operations before income taxes
 
$
634

 
$
503

 
 
 
 
 
Depreciation
 
 
 
 
Life Sciences Solutions
 
$
31

 
$
33

Analytical Instruments
 
18

 
17

Specialty Diagnostics
 
19

 
17

Laboratory Products and Services
 
63

 
30

 
 
 
 
 
Consolidated depreciation
 
$
131

 
$
97

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
 
March 31,

 
April 1,

(In millions)
 
2018

 
2017

 
 
 
 
 
Revenues
 
 
 
 
Life Sciences Solutions
 
$
1,499

 
$
1,363

Analytical Instruments
 
1,257

 
1,052

Specialty Diagnostics
 
947

 
866

Laboratory Products and Services
 
2,413

 
1,699

Eliminations
 
(263
)
 
(215
)
 
 
 
 
 
Consolidated revenues
 
5,853

 
4,765

 
 
 
 
 
Segment Income (a)
 
 
 
 
Life Sciences Solutions
 
517

 
433

Analytical Instruments
 
246

 
192

Specialty Diagnostics
 
243

 
233

Laboratory Products and Services
 
280

 
216

 
 
 
 
 
Subtotal reportable segments (a)
 
1,286

 
1,074

 
 
 
 
 
Cost of revenues charges
 
(3
)
 
(31
)
Selling, general and administrative charges, net
 
(8
)
 
(31
)
Restructuring and other costs, net
 
(45
)
 
(24
)
Amortization of acquisition-related intangible assets
 
(444
)
 
(368
)
 
 
 
 
 
Consolidated operating income
 
786

 
620

Other expense, net (b)
 
(152
)
 
(117
)
 
 
 
 
 
Income from continuing operations before income taxes
 
$
634

 
$
503

 
 
 
 
 
Depreciation
 
 
 
 
Life Sciences Solutions
 
$
31

 
$
33

Analytical Instruments
 
18

 
17

Specialty Diagnostics
 
19

 
17

Laboratory Products and Services
 
63

 
30

 
 
 
 
 
Consolidated depreciation
 
$
131

 
$
97

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
 
 
Three Months Ended
 
 
March 31,

 
April 1,

(In millions)
 
2018

 
2017

 
 
 
 
 
Revenues (c)
 
 
 
 
United States
 
$
2,756

 
$
2,377

China
 
541

 
441

Other
 
2,556

 
1,947

 
 
 
 
 
Consolidated revenues
 
$
5,853

 
$
4,765

(c)
Revenues are attributed to countries based on customer location.